OPN has been reported as a potential cerebrospinal fluid biomarker in amyotrophic lateral sclerosis [133,134] and also in neuromyelitis optica (NMO), an inflammatory disease of the CNS affecting the optic nerve and spinal cord [135]. The gene discussed is SPP1; the disease is neuromyelitis optica.